institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published 3 days ago • loading... • Updated 2 days ago

Hims & Hers Under Fire over Copycat Weight Loss Drugs

Summary by The Hill

Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs. Federal regulators are seeking to rein in the online telemedicine platform, which for years has been selling a non-Food and Drug Administration (FDA) approved version of GLP-1 medication semaglutide even though it is…

6 Articles

6 Articles

+4 Reposted by 4 other sources

Hims & Hers under fire over copycat weight loss drugs

Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs. Federal regulators are seeking to rein in the online telemedicine platform, which for years has been selling a non-Food and Drug Administration (FDA) approved version of GLP-1 medication semaglutide even though it is [...]

2 days ago·Cleveland, United States

Read Full Article

Scientific American

Why the FDA is cracking down on compound GLP-1 drugs for weight loss

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications

3 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources6

Leaning Left1Leaning Right0Center5Last Updated2 days agoBias Distribution

83% Center

Bias Distribution

83% of the sources are Center

83% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Scientific American broke the news in 3 days ago on Wednesday, February 18, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics